ArticleInternational journal of pharmaceutics2018

In vivo controlled release of fenretinide from long-acting release depots for chemoprevention of oral squamous cell carcinoma recurrence.

Kari Nieto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.